Diversified Learning Pathways | |
305 Bagaduce Rd Brooksville ME 04617-3803 | |
(207) 664-9474 | |
Not Available |
Full Name | Diversified Learning Pathways |
---|---|
Speciality | Community/behavioral Health |
Location | 305 Bagaduce Rd, Brooksville, Maine |
Authorized Official Name and Position | Lindsae Lorraine Kish (VICE PRESIDENT) |
Authorized Official Contact | 2076649474 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Diversified Learning Pathways 305 Bagaduce Rd Brooksville ME 04617-3803 Ph: (207) 664-9474 | Diversified Learning Pathways 305 Bagaduce Rd Brooksville ME 04617-3803 Ph: (207) 664-9474 |
NPI Number | 1457774598 |
---|---|
Provider Enumeration Date | 01/25/2014 |
Last Update Date | 03/10/2017 |
Identifier | Type | State | Issuer |
---|---|---|---|
1457774598 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
251S00000X | Community/behavioral Health | (* (Not Available)) | Primary |
News Archive
Mesothelioma is an aggressive cancer of the chest cavity that kills about 2000 people a year in the United States.
Nearly 15,000 UK consumers answered questions about their hearing and their knowledge of hearing aids in the most comprehensive and largest survey ever undertaken in this field. The EuroTrak UK study will provide invaluable data for GPs, the NHS, Department of Health and the audiology profession. This study is now being publicised by The British Hearing Aid Manufacturers Association (BHAMA).
Diarrhea represents a major condition responsible for pediatric mortality worldwide. The onset of neonatal diarrhea may rapidly lead to life threatening dehydration and malnutrition. Clinical and epidemiologic studies defining severity and etiology are needed in order to improve diagnostic and therapeutic approaches for the management of neonatal diarrhea.
Clinical Data, Inc. today announced that it has raised gross proceeds of approximately $27.8 million through the public offering of 1,945,576 newly issued shares of its common stock at a price of $14.30 per share. All of the shares are being offered by Clinical Data, Inc., which exhausts all remaining shares on its existing shelf registration statement.
A historic rise in high-deductible health insurance plans has US hospitals struggling to give newly price-conscious patients an accurate estimate of their share of healthcare costs. At the same time, with an increasing share of their revenue dependent on patients, hospitals are accelerating efforts to collect patient payments up front to prevent bad debts.
› Verified 6 days ago